MedPath
TGA Approval

CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler (410010)

410010

CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler

Cipla Australia Pty Ltd

May 27, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/cf88db2fa866b2d69958b90291dfa0dc.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7e36b9bebee46218e2f8f6d93c248be7.pdf

Active Ingredients

ipratropium bromide monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler (410010) - TGA 批准文号 | MedPath